InflaRx N.V.
IFRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.07 | 0.09 | 0.25 |
| FCF Yield | -34.58% | -46.77% | -26.49% | -22.94% |
| EV / EBITDA | -2.70 | -1.65 | -3.73 | -2.81 |
| Quality | ||||
| ROIC | -85.14% | -43.29% | -61.36% | -52.80% |
| Gross Margin | -1,900.76% | -743.67% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.05 | 0.89 | 1.14 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | -28.26% | -11.76% | 15.18% | -9.15% |
| Safety | ||||
| Net Debt / EBITDA | 0.39 | 0.28 | 0.49 | 0.47 |
| Interest Coverage | -2,566.39 | -1,260.47 | -1,216.94 | -2,275.42 |
| Efficiency | ||||
| Inventory Turnover | 0.48 | 0.05 | 0.00 | 0.00 |
| Cash Conversion Cycle | 383.44 | 4,296.31 | -2,903.39 | -777.29 |